Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation.

Pasquinucci L, Turnaturi R, Montenegro L, Caraci F, Chiechio S, Parenti C.

Eur J Pharmacol. 2019 Jan 25;847:97-102. doi: 10.1016/j.ejphar.2019.01.031. [Epub ahead of print]

PMID:
30690004
2.

Solid Lipid Nanoparticles Loading Idebenone Ester with Pyroglutamic Acid: In Vitro Antioxidant Activity and In Vivo Topical Efficacy.

Montenegro L, Panico AM, Santagati LM, Siciliano EA, Intagliata S, Modica MN.

Nanomaterials (Basel). 2018 Dec 29;9(1). pii: E43. doi: 10.3390/nano9010043.

3.
4.

Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.

Turnaturi R, Montenegro L, Marrazzo A, Parenti R, Pasquinucci L, Parenti C.

Eur J Med Chem. 2018 Jul 15;155:492-502. doi: 10.1016/j.ejmech.2018.06.017. Epub 2018 Jun 7. Review.

PMID:
29908442
5.

Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives.

Pasquinucci L, Parenti C, Amata E, Georgoussi Z, Pallaki P, Camarda V, Calò G, Arena E, Montenegro L, Turnaturi R.

Pharmaceuticals (Basel). 2018 May 5;11(2). pii: E40. doi: 10.3390/ph11020040.

6.

In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations.

Montenegro L, Turnaturi R, Parenti C, Pasquinucci L.

Pharmaceutics. 2018 Feb 27;10(1). pii: E27. doi: 10.3390/pharmaceutics10010027.

7.

Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy.

Montenegro L, Turnaturi R, Parenti C, Pasquinucci L.

Nanomaterials (Basel). 2018 Feb 5;8(2). pii: E87. doi: 10.3390/nano8020087. Review.

8.

Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect.

Montenegro L, Parenti C, Turnaturi R, Pasquinucci L.

Pharmaceutics. 2017 Dec 10;9(4). pii: E58. doi: 10.3390/pharmaceutics9040058.

9.

Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles.

Montenegro L, Pasquinucci L, Zappalà A, Chiechio S, Turnaturi R, Parenti C.

Pharmaceutics. 2017 Oct 21;9(4). pii: E48. doi: 10.3390/pharmaceutics9040048.

10.

In Vitro Antioxidant Activity of Idebenone Derivative-Loaded Solid Lipid Nanoparticles.

Montenegro L, Modica MN, Salerno L, Panico AM, Crascì L, Puglisi G, Romeo G.

Molecules. 2017 May 27;22(6). pii: E887. doi: 10.3390/molecules22060887.

11.

Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.

Lucia M.

Curr Drug Metab. 2017;18(5):469-480. doi: 10.2174/1389200218666170222152038. Review.

PMID:
28228079
12.

May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?

Losurdo G, Giorgio F, Piscitelli D, Montenegro L, Covelli C, Fiore MG, Giangaspero A, Iannone A, Principi M, Amoruso A, Barone M, Di Leo A, Ierardi E.

World J Gastroenterol. 2016 Sep 21;22(35):8017-25. doi: 10.3748/wjg.v22.i35.8017.

13.

Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages.

Ierardi E, Amoruso A, Giorgio F, Principi M, Losurdo G, Piscitelli D, Buffelli F, Fiore MG, Mongelli A, Castellaneta NM, Giangaspero A, De Francesco V, Montenegro L, Di Leo A.

Saudi J Gastroenterol. 2015 Nov-Dec;21(6):379-85. doi: 10.4103/1319-3767.167189.

14.

Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase.

Principi M, Montenegro L, Losurdo G, Zito A, Devito F, Bulzis G, Carbonara R, Ierardi E, Di Leo A, Ciccone MM.

Scand J Gastroenterol. 2016;51(2):253-5. doi: 10.3109/00365521.2015.1070901. Epub 2015 Jul 25. No abstract available.

PMID:
26212627
15.

Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up.

Losurdo G, Piscitelli D, Giangaspero A, Principi M, Buffelli F, Giorgio F, Montenegro L, Sorrentino C, Amoruso A, Ierardi E, Di Leo A.

World J Gastroenterol. 2015 Jun 28;21(24):7545-52. doi: 10.3748/wjg.v21.i24.7545.

16.

Seronegative celiac disease: where is the specific setting?

Ierardi E, Losurdo G, Piscitelli D, Giorgio F, Sorrentino C, Principi M, Montenegro L, Amoruso A, Di Leo A.

Gastroenterol Hepatol Bed Bench. 2015 Spring;8(2):110-6. Review.

17.

Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.

Montenegro L, Piscitelli D, Giorgio F, Covelli C, Fiore MG, Losurdo G, Iannone A, Ierardi E, Di Leo A, Principi M.

World J Gastroenterol. 2014 Dec 14;20(46):17686-9. doi: 10.3748/wjg.v20.i46.17686.

18.

Idebenone loaded solid lipid nanoparticles: calorimetric studies on surfactant and drug loading effects.

Sarpietro MG, Accolla ML, Puglisi G, Castelli F, Montenegro L.

Int J Pharm. 2014 Aug 25;471(1-2):69-74. doi: 10.1016/j.ijpharm.2014.05.019. Epub 2014 May 17.

PMID:
24845103
19.

Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota?

Montenegro L, Losurdo G, Licinio R, Zamparella M, Giorgio F, Ierardi E, Di Leo A, Principi M.

Curr Drug Saf. 2014;9(3):196-204. Review.

PMID:
24809527
20.

Influence of age and type of underlying disease on complications related to home enteral nutrition: a single Italian center experience.

Barone M, Viggiani MT, Amoruso A, Licinio R, Iannone A, Montenegro L, Scavo MP, Addante I, Di Leo A.

JPEN J Parenter Enteral Nutr. 2014 Nov;38(8):991-5. doi: 10.1177/0148607113498422. Epub 2013 Aug 9.

PMID:
23934935

Supplemental Content

Loading ...
Support Center